← Funder search

Ani Rare Disease Patient Assistance Program Inc

Baudette, MN · EIN 921373884 990-PF tax year 2024

Historical funder research: IRS Form 990-PF filings from US private foundations, showing who funded what in past years. This is not a list of currently open grant calls, and we do not track open RFPs from private foundations. From public IRS Form 990-PF filings (latest on file for this funder: tax year 2024). Coverage: tax years 2019–2025. Freshness: the IRS releases these returns 1.5–2+ years after the tax year ends, so 2025 is still partial and a funder's newest grants may not appear yet. Last updated: November 14, 2026. Filings can contain errors, so confirm current priorities and deadlines with the funder before applying.

Grants paid (tax yr 2024)
$161,781,080
Assets (fair market value)
$5,778,500
Median grant to orgs
$161,781,080
all loaded years
Grants in our data
2
since tax year 2023
Giving by tax year
$76,915,240
2023
1 grants
$161,781,080
2024
1 grants

Year 2025 is still partial because many returns have not been filed or released yet. That is a freshness issue — coverage in our dataset is tax years 2019–2025.

Top recipient states
MN$238,696,320
Cause areas funded

Only 0.0% of this funder's organizational grants could be linked to an IRS cause code.

How to apply (from the 990-PF, tax year 2024)
Form & materials
PATIENTS WILL BE REQUIRED TO SUBMIT AN APPROPRIATE APPLICATION TO THE FOUNDATION TO DETERMINE THE PATIENT'S ELIGIBILITY TO PARTICIPATE IN THE PROGRAM. THE PROGRAM WILL COLLECT APPROPRIATE DOCUMENTATION FROM EACH PATIENT APPLICANT SUFFICIENT TO ESTABLISH THAT PATIENT'S SATISFACTION OF THE LIMITED, TAILORED ELIGIBILITY STANDARDS DISCUSSED ABOVE AND AS IMPLEMENTED BY THE FOUNDATION'S BOARD OF DIRECTORS FROM TIME TO TIME. Application is available at the following: https://www.cortrophin.com/pdfs/purified-cortrophin-gel-patient-assist ance-application.pdf
Deadlines
Program eligibility will be determined on an annual basis and patients who wish to re-enroll in the
Restrictions
The organization plans to distribute a pharmaceutical product donated by ANI Pharmaceuticals, Inc. from its Rare Disease portfolio to eligible patients suffering from covered rare diseases.Patients must permanently reside in the U.S. or a U.S. territory, have a valid prescription for an FDA-approved use of the product, and must either lack health insurance coverage for the product or, to the extent the patient has health insurance, demonstrate that the relevant plan does not adequately cover the costs of the product, based on standards established by the organization's board of directors. Applicants must submit an annual application to demonstrate they meet the applicable eligibility criteria
Recent grants to organizations
RecipientLocationPurpose (as filed)AmountTax yr
Donations USBaudette, MNServe Patients and improving lives$161,781,0802024
Donations USBaudette, MNServe Patients and improving lives$76,915,2402023

Grants to individuals are counted but not named.

Researching funders for a client?

The free funder search finds foundations that funded organizations like your client's, by cause and location. Free templates: multi-client grant calendar, grant tracker. GrantCorral is a workspace for grant consultants with several clients; founding members get 60 days free on Consultant, no card required, then 50% off the first year if they stay.